Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 786.70
-16.85 (-2.10%)
Jan 23, 2026, 3:29 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 16.49 billion as of January 23, 2026. Its market cap has decreased by -21.26% in one year.
Market Cap
16.49B
Enterprise Value
14.19B
Revenue
8.30B
Ranking
n/a
PE Ratio
24.79
Stock Price
786.70
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 16.49B, an increase of 85.82%. That is a compound annual growth rate of 14.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 16.49B | -1.05% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 41.80B |
| Innova Captab | 37.15B |
| RPG Life Sciences | 36.85B |
| Orchid Pharma | 35.28B |
| Solara Active Pharma Sciences | 25.05B |
| Indoco Remedies | 19.09B |
| Beta Drugs | 15.07B |
| Jagsonpal Pharmaceuticals | 11.00B |